Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$526K Sell
26,000
-4,000
-13% -$74K 0.06% 98
2015
Q4
$517K Buy
30,000
+3,500
+13% +$55.7K 0.05% 90
2015
Q3
$387K Hold
26,500
0.04% 101
2015
Q2
$431K Hold
26,500
0.03% 102
2015
Q1
$495K Hold
26,500
0.04% 101
2014
Q4
$578K Hold
26,500
0.04% 93
2014
Q3
$544K Buy
26,500
+4,000
+18% +$89.5K 0.03% 105
2014
Q2
$508K Hold
22,500
0.03% 109
2014
Q1
$549K Hold
22,500
0.03% 105
2013
Q4
$608K Buy
22,500
+800
+4% +$20.1K 0.03% 105
2013
Q3
$578K Sell
21,700
-36,500
-63% -$947K 0.03% 101
2013
Q2
$1.43M Buy
+58,200
New +$1.29M 0.1% 84

Other funds holding ADTN

Killen Group's ADTN Position: Q1 2016 in Review

Killen Group reduced its Adtran (ADTN) stake by 13% in Q1 2016, selling an estimated $74K and leaving 26,000 shares worth $526K. The position accounts for 0.06% of the portfolio, ranked #98.

Killen Group first reported a position in ADTN in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.43M in Q2 2013. 164 funds tracked by Wall St. Rank hold ADTN as of Q1 2016.

  • Killen Group held 26,000 shares of Adtran worth $526K as of Q1 2016.
  • Killen Group sold 4,000 Adtran shares in Q1 2016, an estimated $74K.
  • Adtran made up 0.06% of Killen Group's portfolio in Q1 2016, its #98 holding.
  • Killen Group first reported a position in Adtran in Q2 2013 and has held it in 12 quarters since.
  • Killen Group's Adtran position peaked at $1.43M in Q2 2013.
  • 164 funds tracked by Wall St. Rank held Adtran as of Q1 2016.

Based on Killen Group's 13F filing for Q1 2016, filed 27 Apr 2016.